Ann: Appendix 4D and Half Year Financial Report, page-11

  1. 309 Posts.
    lightbulb Created with Sketch. 27
    Looking weak now even at 0.07
    trials? They've been on this wagon for years, linking with this medical research group and that Dr. They just have a formula, but other PDT companies have their particular formula that they think can be developed into a winner (perhaps). PDT is not dominated by Invion, one of quite a few.
    wouldn't touch this with a 40 ft....
    ..and of course 6 4 billion shares on issue, should have done a capital reconstruction years ago in my view, too late now me thinks.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
12.5¢
Change
-0.010(7.41%)
Mkt cap ! $10.59M
Open High Low Value Volume
13.5¢ 14.0¢ 12.5¢ $59.92K 456.4K

Buyers (Bids)

No. Vol. Price($)
1 48324 12.5¢
 

Sellers (Offers)

Price($) Vol. No.
13.0¢ 50000 1
View Market Depth
Last trade - 11.45am 16/06/2025 (20 minute delay) ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.